Recurrent ETV6::SYK rearrangement in myeloid malignancies confers partial susceptibility to MEK inhibition.

Autor: Manuelyan K; Department of Dermatology and Venereology, Medical Faculty, Trakia University and UMHAT 'Prof. Dr. St. Kirkovich', Stara Zagora, Bulgaria., Momcheva I; Department of Rheumatology Burgas, University 'Prof. Dr. Asen Zlatarov' Burgas and UMHAT Burgas, Burgas, Bulgaria., Angelova S; Laboratory of Cytogenetics and Molecular Biology, National Haematology Hospital, Sofia, Bulgaria., Nikolov K; Department of Medical Oncology, Complex Oncology Center, Burgas, Bulgaria., Shivarov V; Department of Experimental Research, Medical University Pleven, Pleven, Bulgaria.
Jazyk: angličtina
Zdroj: British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 382-386. Date of Electronic Publication: 2024 May 19.
DOI: 10.1111/bjh.19549
Databáze: MEDLINE